Search results
Former Merck CEO Ken Frazier on the responsibility of CEOs to uphold principles despite politics
Fortune via Yahoo Finance· 7 months agoOn this week’s episode of Fortune‘s Leadership Next podcast, co-host Alan Murray talks with former...
Shareholders Will Most Likely Find Merck KGaA's (ETR:MRK) CEO Compensation Acceptable
Simply Wall St. via Yahoo Finance· 2 months agoKey Insights Merck KGaA will host its Annual General Meeting on 26th of April CEO Belen Garijo...
Merck keeps deal focus with Keytruda patent cliff on horizon
BioPharma Dive via Yahoo Finance· 4 months agoMerck & Co. plans to continue seeking out multibillion-dollar biotechnology deals to supplement its...
Ken Frazier, long one of the few Black Fortune 500 CEOs, is fighting against ‘the vestiges of the...
Fortune via Yahoo Finance· 8 months agoKen Frazier, former CEO of pharmaceutical company Merck, had a message for CEOs during Fortune’s CEO...
Merck & Co. (MRK) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoImage source: The Motley Fool. Merck & Co. (NYSE: MRK) Q2 2022 Earnings Call Jul 28, 2022, 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers...
At All-Time Highs, Merck's Stock Is Nearing a Cliff
GuruFocus.com via Yahoo Finance· 2 years agoThroughout the beginning of the Covid-19 pandemic, pharmaceutical companies were mostly focused on the availability and effectiveness of vaccines....
Merck & Co., Inc. (NYSE:MRK) Shares Could Be 50% Below Their Intrinsic Value Estimate
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Merck fair value estimate is US$215 Merck...
Sanders threatens to subpoena J&J, Merck CEOs over drug prices
BioPharma Dive via Yahoo Finance· 5 months agoA Congressional committee may subpoena the CEOs of Johnson & Johnson and Merck & Co. to testify...
Merck to buy eye drug developer for $1.3B
BioPharma Dive via Yahoo Finance· 2 weeks agoAn acquisition of EyeBio will hand Merck a treatment for diabetic macular edema and age-related macular degeneration that’s ready for pivotal testing.
Merck upgrades guidance on stronger 2023 outlook as COVID business declines
Yahoo Finance via AOL· 10 months agoMerck (MRK) reported earnings and upgraded its 2023 guidance Tuesday, as demand slows for COVID...